News

LVADs Open Window to Myocardial Recovery : Structural and functional changes in the recovering heart may guide future treatments.


 

The study was sponsored by the National Institutes of Health, the American Heart Association, and the National Institutes for Health Research Cardiovascular Biomedical Research Unit at the Royal Brompton and Harefield National Health Service Foundation Trust, and Imperial College London. Several of the authors reported receiving research support and/or honoraria or speakers fees from Thoratec, Heartware Inc., and Medtronic, all manufacturers of LVADs.

Pages

Recommended Reading

Lack of Congestion Not Predictive in Acute HF
MDedge Cardiology
Gene Therapy Trial Yields Promising Outcomes
MDedge Cardiology
Glycemic Control Influences Heart Failure Risk
MDedge Cardiology
CRT Plus ICD May Reduce Mortality in Mild Heart Failure
MDedge Cardiology
High Cardiac Troponin T Doubles Event Risk
MDedge Cardiology
Telemonitoring Flops in Heart Failure Trials
MDedge Cardiology
Daily Omega-3 Fatty Acids Benefit HF Patients
MDedge Cardiology
Worsening Depression Linked to HF Outcome
MDedge Cardiology
High-Normal Hematocrit Predicts Increased Heart Failure
MDedge Cardiology
Fixed AV Delay Works Well for Most CRT Users
MDedge Cardiology